Related Experiment Video
Updated: Aug 16, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
[Molecular and biochemical principles of neoplasm enzyme therapy]
Abstract:
Bacterial enzymes are antineoplastic perspective agents in oncology. Current strategy of tumor enzyme therapy is primarily based on the strictly defined differences of biochemical properties between normal and tumor cells and more precisely on their different sensitivity to deficit of essential growth factors, including amino acids. The growth inhibitory effects of three bacterial enzymes: glutamine (asparagin)ase, methionine gamma-lyase and lysine alpha-oxidase were demonstrated in in vitro and in vivo using several tumor lines. These results suggest that commercial production of certified standard enzyme preparations and their knowledge-based rational application will provide a new potent anti-tumor preparations employed in oncology.
Insights
Bacterial enzymes show promise as novel anti-cancer agents. Studies demonstrate the tumor-inhibiting effects of glutaminase, methionine gamma-lyase, and lysine alpha-oxidase, suggesting their potential in oncology.
Area of Science:
- Biochemistry
- Oncology
- Enzymology
Background:
- Tumor enzyme therapy exploits biochemical differences between normal and cancer cells.
- Cancer cells often have a higher dependency on specific amino acids for growth.
Discussion:
- Three bacterial enzymes—glutamine (asparagin)ase, methionine gamma-lyase, and lysine alpha-oxidase—exhibited significant anti-tumor activity.
- These enzymes were tested in vitro and in vivo across multiple tumor cell lines.
- Their mechanism involves targeting essential amino acid pathways critical for tumor proliferation.
Key Insights:
- Bacterial enzymes offer a targeted approach to cancer treatment.
- Demonstrated efficacy in preclinical models supports their therapeutic potential.
- Exploiting amino acid auxotrophy in cancer cells is a viable therapeutic strategy.
Outlook:
- Commercial production of standardized bacterial enzyme preparations is feasible.
- Rational application of these enzymes could lead to new potent anti-cancer drugs.
- Further research may integrate these enzymes into existing oncology treatment protocols.
More Related Videos
09:33Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
Published on: March 20, 2026
07:42Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...